Clinical Trial: Study of DISC-0974-201 in Participants With IBD and Anemia

U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07368972) titled 'Study of DISC-0974-201 in Participants With IBD and Anemia' on Jan. 22.

Brief Summary: This is a Phase 2, multicenter, randomized, double-blind placebo-controlled study of DISC-0974 to evaluate safety, tolerability, and efficacy in participants with IBD and anemia of inflammation.

Study Start Date: Jan., 2026

Study Type: INTERVENTIONAL

Condition: Inflammatory Bowel Disease (IBD) Anemia Inflammatory Bowel Disease (IBD); Anemia

Intervention: DRUG: DISC-0974

DISC-0974 is administered subcutaneously.

DRUG: Placebo

Placebo is administered subcutaneously

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Disc Medicine, Inc

Publis...